[1] von Herrath MG.Pathogenesis of type 1 diabetes:a viewpoint[J].Adv Exp Med Biol, 2004, 552(2):317-321. [2] Denis D.Type 1 diabetes[J].Lancet, 2006, 367(9513): 847-858. [3] Miller BJ, Appel MC, O' Neill JJ, et al.Both the Lyt2 + and L3T4+ T cell subsets are required for the transfer of diabetes in nonobeses diabetic mice [J].J Immunol, 1988, 140(1):52-58. [4] Christianson SW, Schultz LD, Leiter ED.Adoptive transfer of diabetes into immunodeficient NOD-scid scid mice. Relative contributions of CD4+ and CD8+ T cells from diabetic versus prediabetic NOD.NON-Thy-la donors[J].Diabetes, 1993, 42(1):44-55. [5] Soderstrom I, Bergman ML, Colussi F, et al.Establish-° 1148° Chin J Clin Pharmacol Ther 2009 Oct;14(10) ment and characterization of RAG-2 deficient non-obese diabetic mice[J].Scand J Immunol, 1996, 43(3):525-530. [6] Christianson SW, Shultz LD, Leiter EH.Adoptive transfer of diabetes into immunodeficient NOD-scid scid mice:relative contributions of CD4+ and CD8+ T cells from diabetic versus prediabetic NOD.NOD-Thy-la donors [J].Diabetes, 1993, 42(1):44-55. [7] Mosmann TR, Coffman RL.Two types of mouse helper T cell clone:implications for immune regulation[J].Immunol, Today, 1987, 8(7):223-227. [8] Mosmann TR, Coffiman RL.TH1 and TH2 cells, different patterns of lymphokine secretion lead to different functional properties[J].Ann Rev Immunol, 1989, 7(7):145-173. [9] Abbas AK, Murphy KM, Sher A.Functional diversity of helper lymphocytes[J].Nature(Lond), 1996, 383(11): 787-793. [10] Trembleau S, Penna G, Bosi E, et al.Interleukin 12 administration induces T helper type 1 cells and accelerates autoimmune diabetes[J].J Exp Med, 1995, 181(2):817-821. [11] Healey D, Ozegbe P, Arden S, et al.In vivo activity and in vitro specificity of CD4+ Th1 and Th2 cells derived from the spleens of diabetic NOD mice [J].J Clin Invest, 1995, 95(6):2979-2985. [12] Katz JD, Benoist C, Mathis D.T helper cell subsets in insulin-dependent diabetes [J]. Science, 1995, 268(5214):1185-1188. [13] Elias D, Cohen IR.The hsp60 peptide p277 arrests the autoimmune diabetes induced by the toxin streptozotocin [J].Diabetes, 1996, 45(9):1168-1172. [14] Tian J, Clare-Salzler M, Herschenfeld A, et al.Modulating autoimmune responses to GAD inhibits disease progression and prolongs islet graft survival in diabetes-prone mice [J].Nature Med, 1996, 2(8):1348-1353. [15] Ramiya VK, Shang XZ, Pharis PG, et al.Antigen based therapies to prevent diabetes in NOD mice[J].J Autoimmun, 1996, 184(9):349-356. [16] Tisch R, Wang B, Serreze DV.Induction of glutamic acid decarboxylase 65-specific Th2 cells and suppression of autoimmune diabetes at late stages of disease is epitope dependent[J].J Immunol, 1999, 163(3):1178-1187. [17] Quintana FJ, Carmi P, Cohen IR.DNA vaccination with heat shock protein 60 inhibits cyclophosphamide-accelerated diabetes[J].J Immunol, 2002, 169(10):6030-6035. [18] Roep BO.T cell responses to autoantigens in IDDM:the search for the Holy Grail[J].Diabetes, 1996, 45(9): 1147-1156. [19] Elias D, Markovits D, Reshef T, et al.Cohen.Induction and therapy of autoimmune diabetes in the non-obese diabetic (NOD Lt) mouse by a 65-kDa heat shock protein [J].Proc Natl Acad Sci USA, 1990, 87(4):1576-1580. [20] Elias D, Reshef T, Birk OS, et al.Vaccination against autoimmune mouse diabetes with a T cell epitope of the human 65-kDa heat shock protein[J].Proc Natl Acad Sci USA, 1991, 88(8):3088-3091. [21] Jana B, Elias D, Cohen IR.Treatment of NOD Diabetes with a Novel Peptide of the hsp60 Molecule Induces Th2- type Antibodies[J].J Autoimmun, 1997, 10(4):323-329. [22] Francisco J, Quintana AR, Pnina C, et al.Vaccination with empty plasmid DNA or CpG oligonucleotide inhibits diabetes in nonobese diabetic mice:modulation of spontaneous 60-kDa heat shock protein autoimmunity[J].J Immunol, 2000, 165(11):6148-6155. [23] Jin L, Yu W, Qiyan X, et al.Long-lasting specific antibodies against P277 induced by mucosal administration of P277 repeat sequences carried by Hsp65 in the absence of adjuvants[J].Vaccine, 2007, 25(11):2043-2050. [24] Jin L, Aihua Z, Yu W, et al.Enhanced immunogenicity of peptide P277 by heat shock protein HSP65 vector carrying tandem repeats of P277 to prevent type 1 diabetes in NOD mice[J].Exp Clin Endocrinol Diabetes, 2008, 116(1):1-8. [25] Mario F, Fornasiero MC, Isetta AM.MTT colorimetric for testing macrophage cytotoxic activity in vitro[J].JIM, 1990, 131(6):165-172. [26] Francisco J, Quintana A, Pnina RC, et al.Vaccination with empty plasmid DNA or CpG oligonucleotide inhibits diabetes in nonobese diabetic mice:modulation of spontaneous 60 -kDa heat shock protein autoimmunity [J].J Immunol, 2000, 165(11):6148-6155. [27] Birk OS, Elias D, Weiss AS, et al.NOD mouse diabetes: the ubipuitous mouse hsp60 is a β-cell target antigen of autoimmune T cells[J].J Autoimmun, 1996, 9(7):159-166. [28] Elias D, Meilin A, Ablamunits V, et al.Hsp60 peptide therapy of NOD mouse diabetes induces a Th2 cytokine burst and downregulates autoimmunity to various β-cell antiges[J].Diabetes, 1997, 46(5):758-764. [29] Michal CS, Gabriel N, Meirav PF, et al.Heat shock protein 60 activates B cells via the TLR4-MyD88 pathway[J]. J Immunol, 2005, 175(6):3594-3602. [30] Jide T, Zekzer D, Hanssen L, et al.Lipopolysaccharideactivated B cells down-regulate Th1 immunity and prevent autoimmune diabetes in nonobese diabetic mice[J].J Immunol, 2001, 167(2):1081-1089. [31] Emiko M, Atsushi M, Frederic IP, et al.Regulatory role of mature B cells in a murine model of inflammatory bowel disease[J].Int Immunol, 2000, 12(5):597-605. [32] Jindal S, Dudani AK, Harley CB, et al.Primary structure of a human mitochondrial protein homologous to the bacte- 中国临床药理学与治疗学 2009 Oct;14(10)° 1149° rial and plant chaperonins and to the 65 kDa mycobacterial antigen[J].Mol Cell Biol, 1989, 9(5):2279-2283. [33] Jin L, Aihua Z, Yu W, et al.A Th1 recognized peptide P277, when tandem repeated, induces a Th2 cytokine burst and toward effective vaccines against autoimmune diabetes in NOD mice[J].J Immunol, 2008, 180(1):58-63. [34] Abehsira-Amar O, Gibert M, Joliy M, et al.IL-4 plays a dominant role in the differential development of Th0 into Thl and Th2 cells[J].J Immunol, 1992, 148(12):3820-3829. [35] Kopf M, Gros GL, BachmannM, et al.Disruption of the murine IL-4 gene blocks Th2 cytokine responses[J].Nature(London), 1993, 362(12):245-248. [36] Mamula MJ, Janeway JCA.Do B cells drive the diversification of immune responses[J] ? Immunol Today, 1993, 14(11):151-154. [37] Kurt-Jones EA, Liano D, HayGlass KA, et al.The role of antigen-presenting B cells in T cell priming in vivo: studies of B cell-deficient mice[J].J Immunol, 1988, 140(6):3773-3777. [38] Grewal IS, Flavell RA.CD40 and CD154 in cell-mediated immunity[J].Annu Rev Immunol, 1998, 16(7):111-135. [39] Chen Y, Kuchroo VJ, Inobe J, et al.Regulatory T cell clones induced by oral tolerance:suppression of autoimmune encephalomyelitis[J].Science, 1994, 265(5176): 1237-1240. [40] Aaron ART, Harding CV, Canaday DH.Mycobacterium tuberculosis Heat Shock Fusion Protein Enhances Class I MHC Cross-Processing and-Presentation by B Lymphocytes [J].J Immunol, 2005, 174(9):5209-5214. [41] Rossi-Bergmann B, Muller I, Godinho EB.TH1 and TH2 T cell subsets are differentially activated by macrophages and B cells in murine leishmaniasis[J].Infect Immun, 1993, 61(5):2266-2269. [42] Hollsberg P, Batra V, Dressel A, et al.Induction of anergy in CD8 T cells by B cell presentation of antigen[J].J Immunol, 1996, 157(12):5269-5276. [43] Adorini L, Guery JC, Ria F, et al.B cells present antigen to CD41 T cells, but fail to produce IL-12:selective APC for Th2 cell development[J] ? Ann NY Acad Sci, 1997, 815(7):401-411. [44] Croft M, Joseph SB, Miner KT.Partial activation of naive CD4 T cells and tolerance induction in response to peptide presented by resting B cells[J].J Immunol, 1997, 159(7):3257-3265. [45] Buktenica S, Olenick SJ, Salgia R, et al.Degradation and regurgitation of extracellular proteins by cultured mouse peritoneal macrophages and baby hamster kidney fibroblasts: kinetic evidence that the transfer of proteins to lysosomes is not irreversible[J].J Biol Chem, 1987, 262(20):9469-9476. [46] Lanzavecchia A.Antigen uptake and accumulation in antigenspecific B cells[J].Immunol Rev, 1987, 99(10):39-51. [47] Lazzarino DA, Blier P, Mellman I.The monomeric guanosine triphosphatase rab4 controls an essential step on the pathway of receptor-mediated antigen processing in B cells[J].J Exp Med, 1998, 188(10):1769-1774. [48] Cheng PC, Steele CR, Gu L, et al.MHC class II antigen processing in B cells:accelerated intracellular targeting of antigens[J].J Immunol, 1999, 162(12):7171-7180 |